A new study from the University of Michigan reveals that dysfunctional mitochondria in cells, particularly in pancreatic B-cells, can lead to Type 2 diabetes by triggering a stress response that affects cell maturity. This mitochondrial signaling could be a key target for future therapies to manage metabolic disorders.